Utility of EVendo Score as a Screening Tool for the Detection of High Risk Esophageal Varices in Pakistani Population

Mahboob Jan

Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Pakistan.

Raja Taha Yaseen Khan *

Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Pakistan.

Hina Ismail

Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Pakistan.

Saleem Shahzad

Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Pakistan.

Abbas Ali Tasneem

Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Pakistan.

Muhammad Qaiser Panezai

Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Pakistan.

Danish Kumar

Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Pakistan.

Nasir Mehmood

Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Pakistan.

Muhammad Adeel

Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Pakistan.

Muhammad Ali Khalid

Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Pakistan.

Ghulamullah Lail

Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Pakistan.

Abdullah Nasir

Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Pakistan.

Nasir Hasan Luck

Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Pakistan.

*Author to whom correspondence should be addressed.


Abstract

Introduction: Endoscopy for the screening of esophageal varices (EVs) is costly and cannot be performed in remote areas with limited resources. Recently, certain non-invasive cost effective models have been proposed for the prediction of EVs but have failed recommendation on a larger scale. EVendo score is a recently developed bedside score for the detection of EVs. Therefore, our aim was to determine the utility of EVendo score as a screening tool for the detection of high risk esophageal varices in Pakistani population.

Methods: It was a cross sectional study which was conducted in the department of Hepatogastroenterology from January 2021-June 2022.All the patients of either gender aged greater than 18 years with newly diagnosed cirrhosis were included in the study while those patients with prior history of esophageal varices and variceal bleeding as well as those with acute liver failure, renal impairment, non-cirrhotic portal hypertension and those on anticoagulants were excluded from the study. Area under the receiver operating curve (AUROC) was obtained for EVendo score, Aspartate Transaminase to platelet ratio(APRI) and Platelet count to Splenic Diameter and diagnostic accuracy was obtained for these scores in predicting EVs and also in identifying HRVs.

Results: A total of 272 patients were enrolled in the study. Among them, 167(61.4%) were males. Most common cause of chronic liver disease was viral hepatitis.On screening endoscopy, EVs were noted in 118(43.4%) patients while high risk EVs (HRV) were noted in 47(17.3%) patients respectively. AUROC was obtained for EVendo score, APRI and Platelet count to Splenic Diameter in predicting EVs and also for identifying HRVs and it was 0.93 (p-value <0.001), 0.821(<0.001) and 0.842(p<0.001) respectively for the prediction of EVs with diagnostic accuracy of 86.76% and 0.852 (p-value <0.001), 0.835(<0.001) and 0.814(p<0.001) respectively for identifying HRVs with a diagnostic accuracy of 84.19%.

Conclusion: The performance of EVendo score was reliable and better than the other non-invasive scores in predicting EVs in our population with an excellent sensitivity and diagnostic accuracy in predicting the EVs and also in identifying HRVs. However, studies comprising larger sample sizes are required in this regard.

Keywords: EVendo, esophageal varices, high risk varices


How to Cite

Jan , M., Khan , R. T. Y., Ismail , H., Shahzad , S., Tasneem , A. A., Panezai , M. Q., Kumar , D., Mehmood , N., Adeel , M., Khalid , M. A., Lail , G., Nasir , A., & Luck , N. H. (2023). Utility of EVendo Score as a Screening Tool for the Detection of High Risk Esophageal Varices in Pakistani Population. Journal of Advances in Medicine and Medical Research, 35(14), 105–113. https://doi.org/10.9734/jammr/2023/v35i145061

Downloads

Download data is not yet available.

References

Rigo GP, Merighi A, Chahin NJ, et al. A prospective study of the ability of three endoscopic classifications to predict hemorrhage from esophageal varices. Gastrointest Endosc. 1992;38:425–429.

Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2017;65:310–335.

Mallet M, Rudler M, Thabut D. Variceal bleeding in cirrhotic patients. Gastroenterol Rep (Oxf) 2017;5:185–92.

Kim BK, Han KH, et al. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. Am J Gastroenterol. 2010;105:1382–90.

Correia LM, Bonilha DQ, Gomes GF, et al. Sedation during upper GI endoscopy in cirrhotic outpatients: a randomized, controlled trial comparing propofol and fentanyl with midazolam and fentanyl. Gastrointest Endosc. 2011;73:45–51.

de Franchis R, Baveno VI faculty. Expanding consensus in portal hypertension: Report of the baveno VI consensus workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–752.

Sousa M, Fernandes S, Proença L, et al. The baveno VI criteria for predicting esophageal varices: validation in real life practice. Rev Esp Enferm Dig. 2017;109:704–707.

Colli A, Gana JC, Yap J, et al. Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of esophageal varices in people with chronic liver disease or portal vein thrombosis. Cochrane Database Syst Rev. 2017; 4:CD008759.

Hanafy AS, Badawi R, Basha MAA, Selim A, Yousef M, Elnawasany S, Mansour L, Elkhouly RA, Hawash N, Abd-Elsalam S. A novel scoring system for prediction of esophageal varices in critically ill patients. Clin Exp Gastroenterol. 2017;10:315-325.

Khan RTY. Bedside utility of liaoning score a non-invasive as predictor of esophageal varices in hepatitis C associated chronic liver disease in Pakistani population. Clin Onco. 2022;6(9):1-6

Dong TS, Kalani A, Aby ES, Le L, Luu K, Hauer M, Kamath R, Lindor KD, Tabibian JH. Machine learning-based development and validation of a scoring system for screening high-risk esophageal varices. Clinical Gastroenterology and Hepatology, 2019;17(9):1894-1901. Available:https://doi.org/10.1016/j.cgh.2019.01.025

Alswat K, Alanazi M, Bashmail A, Alkhamash M, Alqahtani SA, Al-Hamoudi W, Abdo AA. Validation of the EVendo score for the prediction of varices in cirrhotic patients. Saudi J Gastroenterol. 2022;28(5):378-384.

DOI: 10.4103/sjg.sjg_624_21. PMID: 35229755; PMCID: PMC9752538

Korula J. Platelet count/spleen diameter ratio predicted the presence of esophageal varices in liver cirrhosis. ACP J Club. 2004;140(2):53.

Idezuki Y. General rules for recording endoscopic findings of esophagogastric varices (1991). Japanese Society for Portal Hypertension. World J Surg 1995;19:420-422.

Stefanescu H, Grigorescu M, Lupsor M, Procopet B, Maniu A, Badea R. Spleen stiffness measurement using Fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients. J GastroenterolHepatol. 2011;26(1):164-70.

Baig WW, Nagaraja MV, Varma M, et al. Platelet count to spleen diameter ratio for the diagnosis of esophageal varices: Is it feasible? Can J Gastroenterol 2008; 22:825–828.

Chalasani N, Imperiale TF, Ismail A, et al. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol 1999;94:3285–3291.

Stafylidou M, Paschos P, Katsoula A, Malandris K, Ioakim K, Bekiari E, et al. Performance of Baveno VI and expanded Baveno VI criteria for excluding high-risk varices in patients with chronic liver diseases: A systematic review and meta-analysis. Clin Gastroenterol Hepatol 2019;17:1744-55.e11

Suk KT. Hepatic venous pressure gradient: clinical use in chronic liver disease. Clin Mol Hepatol 2014;20:6–14.

Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464–470.

Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006;43:1317–1325.